Cell free DNA of tumor origin induces a 'metastatic' expression profile in HT-29 cancer cell line

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Furi, István ^b   Kalmár, Alexandra ^a   Wichmann, Barnabás ^b   Spisák, Sándor ^b   Schöller, Andrea ^a   Barták, Barbara ^a   Tulassay, Zsolt ^b   Molnár, Béla ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CELL FREE DNA; CYTOKERATIN 20; DNA; DNA METHYLTRANSFERASE 3A; FIBROBLAST GROWTH FACTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; STIMULATOR OF INTERFERON GENE PROTEIN; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; FGF2 GENE; GENE EXPRESSION; HT 29 CELL LINE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; METASTASIS; PARACRINE SIGNALING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HT-29 CELL LINE; METABOLISM; TUMOR GENE;

DNA; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HT29 CELLS; HUMANS; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION;

EID: 84940025278     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131699     Document Type: Article

References (42)

1. Vaisanen MR, Vaisanen T, Jukkola-Vuorinen A, Vuopala KS, Desmond R, Selander KS, et al. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors. The Prostate. 2010; 70(8):817-24. doi: 10.1002/pros.21115 PMID: 20054821.
2. Aggarwal SK, Wagner RW, McAllister PK, Rosenberg B. Cell-surface-associated nucleic acid in tumorigenic cells made visible with platinum-pyrimidine complexes by electron microscopy. Proceedings of the National Academy of Sciences of the United States of America. 1975; 72(3):928-32. PMID: 48252; PubMed Central PMCID: PMC432435.
3. Juckett DA, Rosenberg B. Actions of cis-diamminedichloroplatinum on cell surface nucleic acids in cancer cells as determined by cell electrophoresis techniques. Cancer research. 1982; 42(9):3565-73. PMID: 6286110.
4. Russell JL, Golub ES. Leukemia in AKR mice: a defined suppressor cell population expressing membrane-associated DNA. Proceedings of the National Academy of Sciences of the United States of America. 1978; 75(12):6211-4. PMID: 366615; PubMed Central PMCID: PMC393149.
5. Wen F, Shen A, Choi A, Gerner EW, Shi J. Extracellular DNA in pancreatic cancer promotes cell invasion and metastasis. Cancer research. 2013; 73(14):4256-66. doi: 10.1158/0008-5472.CAN-12-3287 PMID: 23722544; PubMed Central PMCID: PMC3777608.
6. Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. The Journal of experimental medicine. 2005; 202(8):1131-9. doi: 10.1084/jem.20050914 PMID: 16230478; PubMed Central PMCID: PMC2213213.
7. Furi I, Sipos F, Germann TM, Kalmar A, Tulassay Z, Molnar B, et al. Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects. World journal of gastroenterology: WJG. 2013; 19(26):4119-26. doi: 10.3748/wjg.v19.i26.4119 PMID: 23864774; PubMed Central PMCID: PMC3710413.
8. Pinto A, Morello S, Sorrentino R. Lung cancer and Toll-like receptors. Cancer immunology, immunotherapy: CII. 2011; 60(9):1211-20. doi: 10.1007/s00262-011-1057-8 PMID: 21789594.
9. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer research. 2001; 61(4):1659-65. PMID: 11245480.
10. Diehl F, Li M, Dressman D, He Y, Shen D, Szabo S, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(45):16368-73. doi: 10.1073/pnas.0507904102 PMID: 16258065; PubMed Central PMCID: PMC1283450.
11. Gormally E, Caboux E, Vineis P, Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutation research. 2007; 635(2-3): 105-17. doi: 10.1016/j.mrrev.2006.11.002 PMID: 17257890.
12. Chen Z, Fadiel A, Naftolin F, Eichenbaum KD, Xia Y. Circulation DNA: biological implications for cancer metastasis and immunology. Medical hypotheses. 2005; 65(5):956-61. doi: 10.1016/j.mehy.2005.04.042 PMID: 16054303.
13. Lee TH, Chennakrishnaiah S, Audemard E, Montermini L, Meehan B, Rak J. Oncogenic ras-driven cancer cell vesiculation leads to emission of double-stranded DNA capable of interacting with target cells. Biochemical and biophysical research communications. 2014; 451(2):295-301. doi: 10.1016/j.bbrc.2014.07.109 PMID: 25086355.
14. Barber GN. Cytoplasmic DNA innate immune pathways. Immunological reviews. 2011; 243(1):99-108. doi: 10.1111/j.1600-065X.2011.01051.x PMID: 21884170.
15. Ewaschuk JB, Backer JL, Churchill TA, Obermeier F, Krause DO, Madsen KL. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infection and immunity. 2007; 75(5):2572-9. doi: 10.1128/IAI.01662-06 PMID: 17325049; PubMed Central PMCID: PMC1865769.
16. Li J, Huang Q, Zeng F, Li W, He Z, Chen W, et al. The prognostic value of global DNA hypomethylation in cancer: a meta-analysis. PloS one. 2014; 9(9):e106290. doi: 10.1371/journal.pone.0106290 PMID: 25184628; PubMed Central PMCID: PMC4153632.
17. Ilvesaro JM, Merrell MA, Swain TM, Davidson J, Zayzafoon M, Harris KW, et al. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. The Prostate. 2007; 67(7):774-81. doi: 10.1002/pros.20562 PMID: 17373717.
18. Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E, et al. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Molecular cancer research: MCR. 2006; 4(7):437-47. doi: 10.1158/1541-7786.MCR-06-0007 PMID: 16849519.
19. Zhang Y, Wang Q, Ma A, Li Y, Li R, Wang Y. Functional expression of TLR9 in esophageal cancer. Oncology reports. 2014; 31(5):2298-304. doi: 10.3892/or.2014.3095 PMID: 24647486.
20. Sha HL, Ouyang WX, Lu G. [Expression and clinical significance of TLR9 in ovarian cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology]. 2010; 32(12):913-6. PMID: 21223799.
21. Gonzalez-Reyes S, Marin L, Gonzalez L, Gonzalez LO, del Casar JM, Lamelas ML, et al. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC cancer. 2010; 10:665. doi: 10.1186/1471-2407-10-665 PMID: 21129170; PubMed Central PMCID: PMC3009680.
22. Woo SR, Fuertes MB, Corrales L, Spranger S, Furdyna MJ, Leung MY, et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity. 2014; 41(5):830-42. doi: 10.1016/j.immuni.2014.10.017 PMID: 25517615.
23. Abe T, Harashima A, Xia T, Konno H, Konno K, Morales A, et al. STING recognition of cytoplasmic DNA instigates cellular defense. Molecular cell. 2013; 50(1):5-15. doi: 10.1016/j.molcel.2013.01.039 PMID: 23478444; PubMed Central PMCID: PMC3881179.
24. Wu J, Sun L, Chen X, Du F, Shi H, Chen C, et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 2013; 339(6121):826-30. doi: 10.1126/ science.1229963 PMID: 23258412; PubMed Central PMCID: PMC3855410.
25. Temizoz B, Kuroda E, Ohata K, Jounai N, Ozasa K, Kobiyama K, et al. TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN. European journal of immunology. 2014. doi: 10. 1002/eji.201445132 PMID: 25529558.
26. Bronte V. Tumors STING adaptive antitumor immunity. Immunity. 2014; 41(5):679-81. doi: 10.1016/j.immuni.2014.11.004 PMID: 25517609.
27. Deng L, Liang H, Xu M, Yang X, Burnette B, Arina A, et al. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. Immunity. 2014; 41(5):843-52. doi: 10.1016/j.immuni.2014.10.019 PMID: 25517616.
28. Furi I, Sipos F, Spisak S, Kiszner G, Wichmann B, Scholler A, et al. Association of self-DNA mediated TLR9-related gene, DNA methyltransferase, and cytokeratin protein expression alterations in HT29-cells to DNA fragment length and methylation status. TheScientificWorldJournal. 2013; 2013:293296. doi: 10.1155/2013/293296 PMID: 24459426; PubMed Central PMCID: PMC3891537.
29. Xia Y, Li B, Gao N, Xia H, Men Y, Liu Y, et al. Expression of tumor-associated calcium signal transducer in patients with salivary adenoid cystic carcinoma: Correlation with clinicopathological features and prognosis. Oncology letters. 2014; 8(4):1670-4. doi: 10.3892/ol.2014.2400 PMID: 25202389; PubMed Central PMCID: PMC4156178.
30. Blumenthal RD, Hansen HJ, Goldenberg DM. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Cancer research. 2005; 65(19):8809-17. doi: 10.1158/0008-5472.CAN-05-0420 PMID: 16204051.
31. Konig B, Koch A, Spielmann J, Hilgenfeld C, Hirche F, Stangl GI, et al. Activation of PPARalpha and PPARgamma reduces triacylglycerol synthesis in rat hepatoma cells by reduction of nuclear SREBP-1. European journal of pharmacology. 2009; 605(1-3):23-30. PMID: 19248225.
32. Dong XY, Wang GQ, Zhang GQ, Ni ZH, Suo J, Cui J, et al. The endothelial lipase protein is promising urinary biomarker for diagnosis of gastric cancer. Diagn Pathol. 2013; 8. Artn 45 doi: 10.1186/1746-1596-8-45 PMID: WOS:000317238900001.
33. Zhu Z, Zhang X, Guo H, Fu L, Pan G, Sun Y. CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway. Molecular and cellular biochemistry. 2015; 400(1-2):287-95. doi: 10.1007/s11010-014-2285-y PMID: 25476740.
34. Ahn J, Konno H, Barber GN. Diverse roles of STING-dependent signaling on the development of cancer. Oncogene. 2015. doi: 10.1038/onc.2014.457 PMID: 25639870.
35. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 1995; 374(6522):546-9. doi: 10.1038/374546a0 PMID: 7700380.
36. Tuomela J, Sandholm J, Kaakinen M, Patel A, Kauppila JH, Ilvesaro J, et al. DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells. Breast cancer research and treatment. 2013; 142(3):477-87. doi: 10.1007/s10549-013-2762-0 PMID: 24212717; PubMed Central PMCID: PMC4238912.
37. Cui Z, Tang J, Chen J, Wang Z. Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis. Cancer cell international. 2014; 14:47. doi: 10.1186/1475-2867-14-47 PMID: 24936152; PubMed Central PMCID: PMC4059478.
38. Yang MH, Hu ZY, Xu C, Xie LY, Wang XY, Chen SY, et al. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochimica et biophysica acta. 2015; 1852(1):166-74. doi: 10.1016/j.bbadis.2014.11.013 PMID: 25446987; PubMed Central PMCID: PMC4268411.
39. Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, et al. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced betacatenin-Tcf/Lef-dependent transcription. Molecular and cellular biology. 2007; 27(21):7703-17. doi: 10. 1128/MCB.01991-06 PMID: 17785436; PubMed Central PMCID: PMC2169068.
40. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li JJ, et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. British journal of cancer. 2009; 101(4):699-706. doi: 10.1038/sj.bjc.6605195 PMID: 19638978; PubMed Central PMCID: PMC2736825.
41. Zhu Y, Zhu M, Lance P. IL1beta-mediated Stromal COX-2 signaling mediates proliferation and invasiveness of colonic epithelial cancer cells. Experimental cell research. 2012; 318(19):2520-30. doi: 10.1016/j.yexcr.2012.07.021 PMID: 22884582.
42. Davis BK, Roberts RA, Huang MT, Willingham SB, Conti BJ, Brickey WJ, et al. Cutting edge: NLRC5- dependent activation of the inflammasome. Journal of immunology. 2011; 186(3):1333-7. doi: 10. 4049/jimmunol.1003111 PMID: 21191067; PubMed Central PMCID: PMC3669680.